Notice of NIAMS Participation in RFA-AT-19-005 "HEAL Initiative: Pragmatic Randomized Controlled Trial of Acupuncture for Management of Chronic Low Back Pain in Older Adults (UG3/UH3 Clinical Trial Required)"

Notice Number: NOT-AR-19-035

Key Dates
Release Date : February 13, 2019

Related Announcements
RFA-AT-19-005

Issued by
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will participate, effective immediately, in the Funding Opportunity Announcement (FOA) RFA-AT-19-005 "HEAL Initiative: Pragmatic Randomized Controlled Trial of Acupuncture for Management of Chronic Low Back Pain in Older Adults (UG3/UH3 Clinical Trial Required)."

The following sections have been updated to reflect the participation of NIAMS in this Funding Opportunity Announcement.

Part 1. Overview Information

The following information has been added:

Components of Participating Organizations:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Catalog of Federal Domestic (CFDA) Number(s):

93.846

Part 2. Section VII. Agency Contacts

The following contacts have been added:

Scientific/Research Contact(s):

Shahnaz Khan, M.P.H
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Phone: 301-451-9893
Email: Shahnaz.Khan@nih.gov

Financial/Grants Management Contact(s):

Erik Edgerton
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-7760
Email: edgertont@mail.nih.gov

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Shahnaz Khan, M.P.H
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Phone: 301-451-9893
Email: Shahnaz.Khan@nih.gov